Profile
ALVO ZTS HLN TAK TEVA ITCI
Company Name Alvotech Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $2.92B $70.23B $48.53B $45.27B $19.40B $14.05B
Employees 1.01K 13.80K 24.56K 49.28K 33.89K 0.86K
CEO Mr. Robert Wessman Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
ALVO ZTS HLN TAK TEVA ITCI
Quant Rating Score 2 3 3 3 1 1
Quant Rating Sell Neutral Neutral Neutral Strong Sell Strong Sell
Trading
ALVO ZTS HLN TAK TEVA ITCI
Last Close $9.68 $159.27 $10.74 $14.36 $16.93 $131.87
High 52 $14.46 $196.48 $10.77 $15.37 $22.77 $131.91
Low 52 $7.8 $144.45 $8.24 $12.6 $12.82 $64.96
Price vs. 52 Week High -33.06 % -18.94 % -0.28 % -6.57 % -25.65 % -0.03 %
Price vs. 52 Week Low 24.1 % 10.26 % 30.34 % 13.97 % 32.06 % 103 %
Total Return
ALVO ZTS HLN TAK TEVA ITCI
1 Month Return 18.05 % 8.35 % 11.53 % 3.53 % 32.06 % 0 %
3 Month Return -24.08 % -7.35 % 10.95 % 6.92 % 0.71 % 3.74 %
6 Month Return -23.72 % -9.93 % 11.76 % 4.21 % -1.05 % 44.45 %
9 Month Return -11.27 % -14.02 % 9.48 % 3.53 % -2.87 % 79.15 %
YTD Return -26.83 % -2.25 % 12.58 % 8.46 % -23.19 % 57.89 %
1 Year Return -27.6 % -5.78 % 30.34 % 8.38 % 4.18 % 103 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALVO ZTS HLN TAK TEVA ITCI
Dividend Yield Percentage (TTM) - 1.18 % 0.02 % 4.63 % - -
Dividend Paid and Capex Coverage Ration (TTM) -4.16 % 2.05 % - 1.76 % 2.5 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 0.07 % 196 % - -
Payout Ratio (TTM) - 31.62 % - 145.09 % - -
Growth
ALVO ZTS HLN TAK TEVA ITCI
Asset Growth 28.56 % 8.25 % -9.55 % 87.69 %
Gross Profit Growth 538.44 % 1.76 % 5.47 % 44.88 %
Revenue Growth 435.56 % 5.87 % 4.4 % 46.62 %
Revenue 3 Year 55.32 % 33.13 % 1.52 % 556.51 %
Revenue 5 Year 1295.18 % 103.83 % -5.5 % 600974.32 %
Revenue 10 Year 1295.18 % 152.69 % -38.45 % 32663.23 %
EBIT Growth 87.51 % -64.98 % -169.63 % 26.77 %
Net Income Growth 57.98 % -54.56 % -193.2 % 46.54 %
Net Income 3 Yeari Growth Per Share 73.36 % -61.74 % -482.97 % 79.29 %
Net Income 5 Yeari Growth Per Share -0.47 % 32.36 % -58.26 % 72.95 %
Net Income 10 Yeari Growth Per Share -0.47 % 35.42 % -140.46 % 32.41 %
Operating Income Growth 119.63 % -56.36 % -169.98 % 26.77 %
Operating Cash Flow Growth (CFG) 24.13 % -26.69 % -8.85 % 41.08 %
Operating 3 Year CFG 87.89 % -29.25 % 52.26 % 77.79 %
Operating 5 Year CFG -143.24 % 118.64 % 123.59 % 69.4 %
Operating 10 Year CFG -143.24 % 384.17 % -81.66 % 10.87 %
EPS Growth 64.2 % -54.92 % -190 % 50.68 %
EPS Diluted Growth 64.2 % -54.86 % -190 % 50.68 %
Book Value Per Share 62.45 % 13.54 % -30.36 % 80.54 %
Share Holder 3 Year Equity Growth Per Share 64.5 % 40.38 % -49 % 116.52 %
Share Holder 5 Year Equity Growth Per Share - 41.33 % -62.86 % 215.14 %
Share Holder 10 Year Equity Growth Per Share - 195.14 % -82.6 % 164.65 %
Dividend Per Share Growth - 1.95 % - -
Dividend 3 Year Growth Per Share - 1.19 % - -
Dividend 5 Year Growth Per Share - 101.42 % -100 % -
Dividend 10 Year Growth Per Share - 102.58 % -100 % -
Debt Growth 10.67 % 10.53 % -10.29 % 0.25 %
Free Cash Flow Growth 18.07 % -31.4 % -11.05 % 40.95 %
Updated On 31 Dec 2024 31 Mar 2024 31 Dec 2024 31 Dec 2024
Profitability
ALVO ZTS HLN TAK TEVA ITCI
Gross Profit Margin TTM 60.17 % 69.85 % 61.52 % 54.74 % 48.74 % 91.63 %
Return on Assets TTM -18.98 % 17.46 % 4.2 % 1.38 % -4.17 % -5.46 %
Return on Equity TTM 45.89 % 49.65 % 8.73 % 2.83 % -26.15 % -7.4 %
Return on Capital Employed TTM 4.39 % 31.33 % 7.74 % 3.62 % -1.14 % -10.05 %
Net Income Per EBT TTM 106.57 % 79.35 % 75.5 % 89.75 % 127.75 % 100.64 %
EBT Per Ebit TTM -481.55 % 92.36 % 86.58 % 49.18 % 423.43 % 63.57 %
EBIT Per Revenue TTM 9.71 % 36.65 % 19.64 % 10.3 % -1.83 % -17.15 %
Cash Flow To Debt Ratio TTM -19.9 % 43.79 % - 22.2 % 6.9 % -430.93 %
Receivables Turnover TTM 1.85 7.03 5.9 6.23 5.41 4.09
Payables Turnover TTM 2.76 6.45 2.19 4.5 3.85 2.18
Inventory Turnover TTM 1.45 1.21 3.63 1.66 2.82 2.17
Fixed Asset Turnover TTM 113.55 % 256.4 % 584.75 % 226.93 % 334.34 % 4569.25 %
Asset Turnover TTM 38.09 % 65.01 % 32.73 % 30.31 % 42.07 % 49.79 %
Operating Cash Flow Per Share TTM -0.78 6.55 - 677.91 1.1 -0.71
Free Cash Flow Per Share TTM -0.97 5.1 - 483.45 0.66 -0.71
Cash Per Share TTM 17.04 % 440.62 % 24.05 % 33229.49 % 291.26 % 970.67 %
Operating Cash Flow Sales Ratio TTM -50.9 % 31.9 % - 23.47 % 7.54 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 124.07 % 77.82 % - 71.32 % 60.06 % 100.44 %
Cash Flow Coverage Ratios TTM -19.9 % 43.79 % - 22.2 % 6.9 % -430.93 %
Price To Free Cash Flows Ratio TTM -9.94 30.56 - 8.69 28.03 -191.12
Price To Operating Cash Flows Ratio TTM -12.34 24.02 - 6.25 16.65 -185.85
Price Cash Flow Ratio TTM -12.34 24.02 - 6.25 16.65 -185.85
Income Statement (TTM)
ALVO ZTS HLN TAK TEVA ITCI
Revenue $0.49B $9.26B $11.23B $4263.76B $16.54B $0.68B
Gross Profit $0.3B $6.54B $6.95B $2832.26B $8.06B $0.62B
Gross Profit Ratio 62.16% 70.62% 61.85% 66.43% 48.74% 91.63%
EBITDA $-0.03B $3.87B $2.51B $874.6B $0.72B $-0.12B
Net Income $-0.23B $2.49B $1.44B $144.07B $-1.64B $-0.07B
EPS Diluted -0.87 5.47 0.32 45.58 -1.45 -0.72
Balance Sheet (MRQ)
ALVO ZTS HLN TAK TEVA ITCI
Long Term Debt $1.15B $5.39B $8.54B $5029.93B $16B $0.01B
Total Liabilities $1.63B $9.47B $18.09B $7834.79B $33.61B $0.22B
Total Equity $-0.41B $4.77B $16.22B $7274.01B $5.73B $1.15B
Total Investments $0.02B $0B $0.08B $445.7B $0B $0.69B
Total Debt $1.19B $6.74B $10.1B $4843.75B $18.08B $0.02B
Total Assets $1.22B $14.24B $34.32B $15108.79B $39.33B $1.37B
Cash Flow Statement (TTM)
ALVO ZTS HLN TAK TEVA ITCI
Net Income $-0.23B $2.5B $1.44B $144.07B $-1.96B $-0.07B
Inventory $-0.05B $-0.04B $0.22B $-115.74B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-0.57B $-287.19B $0B $0B
Operating Cash Flow $-0.24B $2.95B $2.3B $716.34B $1.25B $-0.07B
Capital Expenditure $-0.06B $-0.66B $-0.25B $-480.73B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.85
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.16
ALIM Alimera Sciences, Inc. 5.54
ALVOW Alvotech 1.79
AMPH Amphastar Pharmaceuticals, Inc. 24.11
AMRX Amneal Pharmaceuticals, Inc. 7.41
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 66.3
APUS Apimeds Pharmaceuticals US, Inc 0.00001
AQST Aquestive Therapeutics, Inc. 2.79
ASRT Assertio Holdings, Inc. 0.61
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.39
AYTU Aytu BioPharma, Inc. 1.25
ETFs With Exposure to ALVO
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0.01 46.25
IBB iShares Biotechnology ETF 0.10453 116.63
VEU Vanguard FTSE All-World ex-US Index Fund 0 63.42
VT Vanguard Total World Stock Index Fund 0 118.79
VXUS Vanguard Total Intl Stock Idx Fund 0 64.97
SCHE Schwab Emerging Markets Equity ETF 0.0126448 28.29
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 0.003 38.28
BIB ProShares Ultra Nasdaq Biotechnology 0.114722 39.63
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 70.57
DWAS Invesco DWA SmallCap Momentum ETF 0.199 79.44
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.12 28.02
PZW.TO Invesco FTSE RAFI Global Small-Mid ETF 0.0017 35.26
SPAK Defiance Next Gen SPAC Derived ETF 0.14 14.63
IBBQ Invesco Nasdaq Biotechnology ETF 0.277 19.47
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.26958 5.75
VTSNX Vanguard Total Intl Stock Idx Fund 0 139.56
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.26958 5.743
STXK Ea Series Trust - Strive 2000 ETF 0.05 28.69
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0 39.37
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0.01 38.43
VTIAX Vanguard Total International Stock Index Fd Admiral 0 34.9
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0 42.07
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0.01 97.21
VTWIX Vanguard Total World Stock Index I 0 242.52
VTPSX Vanguard Total Intl Stock Idx InstlPls 0 139.59
RFLR Innovator ETFs Trust 0.05 24.115
GLCR GlacierShares Nasdaq Iceland ETF 9.39 24.0579
Unlock